1. Home
  2. CARE vs VNDA Comparison

CARE vs VNDA Comparison

Compare CARE & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carter Bankshares Inc.

CARE

Carter Bankshares Inc.

N/A

Current Price

$20.47

Market Cap

438.9M

Sector

Finance

ML Signal

N/A

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

N/A

Current Price

$8.61

Market Cap

474.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CARE
VNDA
Founded
1974
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
438.9M
474.0M
IPO Year
2020
2005

Fundamental Metrics

Financial Performance
Metric
CARE
VNDA
Price
$20.47
$8.61
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$14.90
AVG Volume (30 Days)
161.0K
3.6M
Earning Date
04-30-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
30.19
N/A
EPS
1.38
N/A
Revenue
$20,315,000.00
$216,105,000.00
Revenue This Year
$12.50
$21.50
Revenue Next Year
$9.72
$38.67
P/E Ratio
$14.89
N/A
Revenue Growth
4.65
8.72
52 Week Low
$13.61
$3.81
52 Week High
$22.51
$9.60

Technical Indicators

Market Signals
Indicator
CARE
VNDA
Relative Strength Index (RSI) 39.34 59.84
Support Level $19.32 $4.25
Resistance Level $22.46 $9.35
Average True Range (ATR) 0.58 0.56
MACD -0.17 0.09
Stochastic Oscillator 23.55 86.31

Price Performance

Historical Comparison
CARE
VNDA

About CARE Carter Bankshares Inc.

Carter Bankshares Inc is a bank holding company that conducts its business solely through the bank. The Bank earns revenue from interest on loans and securities and fees charged for financial services provided to customers. It offers a full range of deposit services including Lifetime Free Checking, interest checking accounts, savings accounts, retirement accounts and other deposit accounts of various types, ranging from money market accounts to longer-term CDs. The Bank offers a full range of commercial and consumer loans. The Bank also originates and holds fixed and variable-rate mortgage loans and offers home equity lines of credit to its customers.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: